2017 Pivot X, Verma S, Fallowfield L, Muller V, Lichinister M, Jenkins V, Sanchez-Munoz A, Machackova Z, Osborne S and Gligorov J. Efficacy and safety of subcutaneous trastuzumab and intravenous trastuzumab as part of adjuvant therapy for HER2-positive early breast cancer: final analysis of the randomised, two-cohort PrefHer study. European Journal of Cancer. 2017 86:82-90. Online first 27 Sept 2017
2017 Fallowfield L, Nadler E, Gilloteau I, Greaney M, Gater A, Orsini L, Subar M, Lyman GH. Quality of Survival: a new concept framework to assess the quality of prolonged life in cancer. Expert Review of Quality of Life in Cancer Care. 2017:2(4)225-232. Online first 22 Aug 2017
2017 Oberguggenberger A, Martini C, Huber N, Fallowfield N, Hubalek M, Daniaux M, Sperner-Unterweger B, Holzner B, Sztankay M, Gamper E, Meraner V. Self-reported sexual health: Breast cancer survivors compared to women from the general population – an observational study. BioMed Central. Article first published online 30 Aug 2017.
Menon U, McGuire A, Raikou M, Ryan A, Davies S, Burnell S, Gentry-Maharaj A, Kalsi J, Singh N, Amso N, Cruickshanks D, Dobbs S, Godfrey K, Herod J, Leeson S, Mould T, Murdoch J, Oram D, Woolas R, Scott I, Seif M, Williamson K, Fallowfield L, Cambell S, Skates S, Parmar M Jacobs I. The Cost-effectiveness of Screening for Ovarian Cancer: Results from the UK Collaborative Trial of Ovarian Cancer Screening (UKCTOCS). British Journal of Cancer, Aug 22 117(5):619-627. Article first published online 25 Jul 2017.
Silverman J, van Weel-Baumgarten E, Butow P, Fallowfield L, Bylund C, Deveugele M, Rosenbaum M, Martin P, Kinnersley P. A new paradigm or a misrepresentation of current communication research and teaching? Letter to the Editor, Medical Education. Article first published online 27 July 2017.
Harder H, Holroyd P, Burkinshaw L, Watten P, Zammit C, Harris PR, Good A, Jenkins V. A user-centred approach to developing bWell, a mobile app for arm and shoulder exercises after breast cancer treatment. Journal of Cancer Survivorship. Article first published online 24 July 2017.
Shilling V, Starkings R, Jenkins V, Fallowfield LJ. The pervasive nature of uncertainty—a qualitative study of patients with advanced cancer and their informal caregivers. Journal of Cancer Survivorship. Article first published online 18 July 2017.
Gligorov J, Curigliano G, Müller V, Knoop A, Jenkins V, Verma S, Osborne S, Lauer S, Machackova Z, Fallowfield L, Pivot X. Switching between intravenous and subcutaneous trastuzumab: Safety results from the PrefHer trial. The Breast, 2017: 34:89–95. Article first published online 23 May 2017. Print version expected August 2017.
Morden JP, Alvarez I, Bertelli G, Coates AS, Coleman R, Fallowfield L, Jassem J, Jones S, Kilburn L, Lønning PE, Ortmann O, Snowdon C, van de Velde C, Andersen J, Del Mastro L, Dodwell D, Holmberg S, Nicholas H, Paridaens R, Bliss JM, Coombes CR. Long-Term Follow-Up of the Intergroup Exemestane Study. Journal of Clinical Oncology. Article first published online 3 May 2017.
L Fallowfield, I Solis-Trapala, U Menon, C Langridge, S May, I Jacobs, V Jenkins. The effect of ovarian cancer screening on sexual activity and functioning: results from the UK collaborative trial of ovarian cancer screening RCT British Journal of Cancer (2017) 116, 1111–1117. Article first published online 21 March 2017. Restricted access/subscription required.
D Bloomfield, L Fallowfield, S May, V Jenkins. Too Hot, Too Cold or Can We Get it Just Right? What Emotional Distance Should Oncologists Keep from their Patients? Clinical Oncology, 29(4)205-206. First published online first 29 Dec 2016.
Harder H & Jenkins V Chapter 18 “The Effects of Breast Cancer Treatments on Cognition” in Alistair Ring & Marina Parton (Eds) Breast Cancer Survivorship Springer (pp: 235-247)